Empower Pharmacy

Empower Pharmacy is one of the largest and most widely cited FDA-registered 503B outsourcing facilities in the United States. Unlike 503A compounding pharmacies that prepare medications for individual patients, Empower operates as a 503B outsourcing facility, meaning it produces bulk compounded medications under FDA oversight and quality standards that more closely mirror those of pharmaceutical manufacturers. Empower supplies compounded semaglutide, tirzepatide, and other GLP-1 preparations to telehealth platforms, weight loss clinics, and medical practices across the country. The pharmacy is not direct-to-patient — patients must access Empower's products through a registered healthcare provider or platform that sources from their facility. Empower has faced scrutiny as part of the broader FDA review of compounded GLP-1 products in 2025-2026, but has maintained its 503B registration status. The pharmacy is headquartered in Houston, Texas with multiple production facilities. For clinics and telehealth platforms looking for a verified 503B source, Empower is one of the most recognised names in the compounding sector.